The abortion pill mifepristone will remain available in the United States for now but with significant restrictions, including a requirement for in-person doctor visits to obtain the drug, a federal appeals court ruled late on Wednesday.
Dozens of U.S. state attorneys general on Friday weighed in on a lawsuit seeking a court order blocking access nationwide to a drug used in medication abortion, with Republicans in support of the lawsuit and Democrats warning of “devastating consequences” if it succeeds.
The U.S. Food and Drug Administration (FDA) will allow retail pharmacies to offer abortion pills in the United States for the first time, the agency said on Tuesday, even as more states seek to ban medication abortion.
More than 60 abortion clinics across 15 states have stopped providing abortions since the U.S. Supreme Court overturned Roe v. Wade in June, according to a study by the Guttmacher Institute, a reproductive rights advocacy research group.
U.S. President Joe Biden will announce new guidelines and grants to protect reproductive rights on Tuesday, and describe how abortion rights have been curtailed since the Supreme Court overturned the constitutional right to terminating pregnancies.